Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
Zobel, G; Trop, M; Muntean, W; Ring, E; Gleispach, H.
Anticoagulation for continuous arteriovenous hemofiltration in children.
Blood Purif. 1988; 6(2):90-95
Doi: 10.1159/000169489
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
- Co-Autor*innen der Med Uni Graz
- Muntean Eugen
- Ring Ekkehard
- Trop Marija
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Continuous arteriovenous hemofiltration requires continuous anticoagulation to prevent early hemofilter clotting. We used heparin given continuously in the arterial line of the extracorporeal circuit as anticoagulant in children with initially normal coagulation status, and heparin and/or prostacyclin in high-risk bleeding patients with preexisting coagulopathy. Heparin infusion enabled a mean running time of 22.2 +/- 9.6 h, with the 0.1-m2 hemofilter and of 26.6 +/- 4.7 h with the 0.25-m2 hemofilter. The mean filter running time with combined heparin/prostacyclin infusion was 31 +/- 8.8 h. Prostacyclin as the sole antithrombotic agent provided good filter function only in 1 patient with preexisting coagulopathy. No adverse effects such as bleeding thrombosis, or hypotension were observed.
- Find related publications in this database (using NLM MeSH Indexing)
- Anticoagulants - therapeutic use
- Child - therapeutic use
- Child, Preschool - therapeutic use
- Drug Combinations - therapeutic use
- Epoprostenol - therapeutic use
- Hemofiltration - therapeutic use
- Heparin - therapeutic use
- Humans - therapeutic use
- Infant - therapeutic use
- Infant, Newborn - therapeutic use
- Platelet Count - drug effects
- Time Factors - drug effects
- Urea - metabolism